Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17 - PubMed (original) (raw)

Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17

P I Patel et al. Am J Hum Genet. 1990 Apr.

Erratum in

Am J Hum Genet 1990 Jul;47(1):172

Abstract

We have performed linkage analysis in a large French-Acadian kindred segregating one form of autosomal dominant Charcot-Marie-Tooth disease (CMTD) (type IA) using 17 polymorphic DNA markers spanning human chromosome 17 and demonstrate linkage to several markers in the pericentromeric region, including DNA probes pA10-41, EW301, S12-30, pTH17.19, c11-2B, and p11-2c11.5. Linkage of markers pA10-41 and EW301 to CMTD type IA has been reported elsewhere. Four new markers, 1516, 1517, 1541, and LL101, which map to chromosome 17 have been identified. The marker 1516 appears to be closely linked to the CMTD locus on chromosome 17 as demonstrated by a maximum lod score of 3.42 at theta (recombination fraction) = 0. This marker has been mapped to 17p11.2 using a somatic cell hybrid constructed from a patient with Smith-Magenis syndrome [46,XY, del(17)(p11.2p11.2)]. A lod score of 6.16 has been obtained by multipoint linkage analysis with 1516 and two markers from 17q11.2, pTH17.19, and c11-2B. The markers 1517 and 1541 have been mapped to 17p12-17q11.2 and demonstrate maximum lod scores of 2.35 and 0.63 at recombination values of .1 and .2, respectively. The marker LL101 has been mapped to 17p13.105-17p13.100 and demonstrates a maximum lod score of 1.56 at a recombination value of .1. Our study confirms the localization of CMTD type IA to the pericentromeric region of chromosome 17.

PubMed Disclaimer

Cited by

Clan genomics: From OMIM phenotypic traits to genes and biology.
Lupski JR. Lupski JR. Am J Med Genet A. 2021 Nov;185(11):3294-3313. doi: 10.1002/ajmg.a.62434. Epub 2021 Aug 18. Am J Med Genet A. 2021. PMID: 34405553 Free PMC article.
Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success.
Timmerman V, Strickland AV, Züchner S. Timmerman V, et al. Genes (Basel). 2014 Jan 22;5(1):13-32. doi: 10.3390/genes5010013. Genes (Basel). 2014. PMID: 24705285 Free PMC article.
The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes.
Inoue K, Dewar K, Katsanis N, Reiter LT, Lander ES, Devon KL, Wyman DW, Lupski JR, Birren B. Inoue K, et al. Genome Res. 2001 Jun;11(6):1018-33. doi: 10.1101/gr.180401. Genome Res. 2001. PMID: 11381029 Free PMC article.
Inherited neuropathies: from gene to disease.
Keller MP, Chance PF. Keller MP, et al. Brain Pathol. 1999 Apr;9(2):327-41. doi: 10.1111/j.1750-3639.1999.tb00230.x. Brain Pathol. 1999. PMID: 10219749 Free PMC article. Review.

References

1. Methods Enzymol. 1987;152:41-8 - PubMed
1. Science. 1987 May 29;236(4805):1100-2 - PubMed
1. Am J Hum Genet. 1988 May;42(5):756-71 - PubMed
1. Genomics. 1987 Dec;1(4):340-5 - PubMed
1. Genomics. 1987 Dec;1(4):353-7 - PubMed

Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17 - PubMed (original) (raw)